Home/ Supplements/ Nmn/ Liposomal NMN + NR

Liposomal NMN + NR

product on market Capsule GenuinePurity Safety: 80/100
80/100

This product is generally safe

  • Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Beta-Nicotinamide Mononucleotide and Nicotinamide Riboside serve as precursors to NAD+, which supports cellular energy metabolism. Research on these ingredients is generally moderate, though clinical evidence for long-term human efficacy remains limited. The current evidence coverage for this specific formulation is very low.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Liposomal NMN + NR
Open Full PDF View on NIH DSLD →
Details

Label Data

2 VCapsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 7.1× (UL: 35 mg) 196 studies (A:5, B:63)
Market median: 300.0mg (26 products) 7 studies (A:0, B:1)

Other Ingredients

Cellulose Microcrystalline Cellulose Maltodextrin Sunflower Lecithin Phosphatidylcholine Silicon Dioxide Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: 2 capsules daily preferably with meals or as directed by a healthcare professional.

Warnings & Precautions

Caution: Do not exceed recommended dose. Do not purchase if seal is broken.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition including any cardiovascular disorder, hypotension (low blood pressure) and Parkinson's disease.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition including any cardiovascular disorder, hypotension (low blood pressure) and Parkinson's disease. Keep out of the reach of children.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg. peanuts, tree nuts, fish, and crustacean shellfish.

Formulation Notes

Promotes Cellular Regeneration, Mitochondrial Function & DNA Health

Additional Information

Protect from heat, light and moisture. Store at 15 degrees C-30 degrees C (59-86 degrees F).

Please recycle

Made in USA GMP Sourced from a GMP Certified Facility

Metadata

Product Details

UPC / SKU6 28043 00145 9
DSLD Entry Date2025-08-22
Product TypeOther Combinations
FormCapsule
DSLD ID336118
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

View all Nmn products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.